Prohost Biotech - Exclusive Biotech Research - A Comprehensive Resource for Biotech News

Pfizer and BioNTech Submitted an EUA to the FDA for their COVID-19 Vaccine, BNT162b2

November 21, 2020 0

Pfizer, BioNTech & Moderna When asked whether we heard the news about the submission of the …

Why Gilead Sciences Product Lenacapavir Deserves the FDA Granted Breakthrough Therapy Designation. See Also: Cellectis and Sanofi

November 19, 2020 0

Gilead Sciences News Results from Phase 2/3 CAPELLA trial evaluating Gilead Sciences (GILD) lenacapavir achieved the primary …

PTC Therapeutics’ Many Attractive Achievements and Approvals

November 18, 2020 0

PTC Therapeutics Approvals and Achievements PTC Therapeutics (PTCT) has achieved a lot recently. The latest is …

Inovio to Proceed with Phase 2 Trial of INO-4800 Vaccine Candidate for COVID-19

November 16, 2020 0

Inovio Announced FDA Clearance to Proceed with Trial for COVID-19 Vaccine Candidate Inovio (INO) announced the …

Moderna’s Successful COVID-19 Vaccine Results

November 16, 2020 0

Moderna Has Successful COVID-19 Vaccine Results and News Moderna’s Phase 3 study met statistical criteria with …

Moderna’s Future Growth

November 12, 2020 0

Moderna Inc COVID-19 Vaccine Candidate Moderna Inc (MRNA) announced the completion of the case accrual for …

A First in Class Antibody for a Difficult to Treat Stomach Cancer and Maybe Others

November 11, 2020 0

Five Prime Therapeutics Antibody Plus Chemotherapy for Stomach Cancer Five Prime Therapeutics (FPRX) announced positive topline results from …

About bluebird bio

November 10, 2020 0

bluebird bio bluebird bio (BLUE) financial results and business highlights for the third quarter 2020 are …

Pfizer and BioNTech Vaccine Candidate Against COVID-19 Achieved a Sweet Success

November 9, 2020 0

Pfizer and BioNTech Good News Regarding COVID-19 Vaccine Candidate Pfizer (PFE) and BioNTech (BNTX) announced that …

CRISPR Therapeutics – Professor Emmanuelle Charpentier – Gene Editing and the Future of Humanity

November 6, 2020 0

CRISPR Therapeutics Dr. Emmanuelle Charpentier, Co-Founder CRISPR Therapeutics (CRSP) announced on October 7, 2020 that Dr. …

Why Compugen is a Favorite Biotechnology Firm

November 6, 2020 0

Compugen Compugen (CGEN) presented its third-quarter achievements and financial results. We believe the firm is on …

What We Expect to Hear at the Regenxbio Conference Call Today

November 4, 2020 0

Regenxbio Conference Call Information Regenxbio will host a conference call today, at 4:30 pm est today, …

Rhythm Pharmaceuticals Achievements and Q3 Financial Results

November 2, 2020 0

Rhythm Pharmaceuticals Rhythm Pharmaceuticals (RYTM) reported financial results and provided a business update for the third …

Imminent Announcements of Important Quarterly Results

October 28, 2020 0

Important Quarterly Results Announcements Monday, November 2, 2020 at 8:PM ET IVERIC bio IVERIC bio’s (ISEE) …

Why We Expect a Lot from the Following Biotech Firms

October 27, 2020 0

Compugen Compugen (CGEN) announced the presentation of new research data that further support PVRIG as a potentially …

Tracking the News from AstraZeneca About Experimental Vaccine, AZD1222, for COVID-19

October 26, 2020 0

News from AstraZeneca About COVID-19 Vaccine, AZD1222 From AstraZeneca (AZN) we learned that its COVID-19 vaccine, …

The U.S. FDA Approves Gilead Sciences Antiviral Veklury® (remdesivir) for COVID-19

October 23, 2020 0

Gilead Sciences Veklury® (Remdesivir) was Approved by the US FDA The U.S. FDA approved Gilead Sciences …

Ionis Pharmaceuticals News About ALS Treatment Attempts

October 22, 2020 0

Ionis Pharmaceuticals Dosed First Patients with ION541 for ALS Ionis Pharmaceuticals (IONS) announced that the first …

We Continue to Track the COVID-19 Vaccines. See Also: CRISPR Therapeutics Immuno-Oncology Results are Good.

October 21, 2020 0

The Latest on the COVID-19 Vaccines AstraZeneca (AZN): After pausing for more than a month, AZN …

A Great Game Changer for the History of Biotechnology

October 20, 2020 0

Intellia Therapeutics Scientific Co-Founder Shares Nobel Prize in Chemistry with Collaborator On October 07, 2020 Jennifer …

Exclusive Market Insight

& Scientific analysis

Latest Articlesddd

Pfizer and BioNTech Submitted an EUA to the FDA for their COVID-19 Vaccine, BNT162b2

Why Gilead Sciences Product Lenacapavir Deserves the FDA Granted Breakthrough Therapy Designation. See Also: Cellectis and Sanofi

PTC Therapeutics’ Many Attractive Achievements and Approvals

Inovio to Proceed with Phase 2 Trial of INO-4800 Vaccine Candidate for COVID-19

Moderna’s Successful COVID-19 Vaccine Results

Moderna’s Future Growth

A First in Class Antibody for a Difficult to Treat Stomach Cancer and Maybe Others

About bluebird bio

Pfizer and BioNTech Vaccine Candidate Against COVID-19 Achieved a Sweet Success

CRISPR Therapeutics – Professor Emmanuelle Charpentier – Gene Editing and the Future of Humanity

Why Compugen is a Favorite Biotechnology Firm

What We Expect to Hear at the Regenxbio Conference Call Today

Rhythm Pharmaceuticals Achievements and Q3 Financial Results

Imminent Announcements of Important Quarterly Results

Why We Expect a Lot from the Following Biotech Firms

Tracking the News from AstraZeneca About Experimental Vaccine, AZD1222, for COVID-19

The U.S. FDA Approves Gilead Sciences Antiviral Veklury® (remdesivir) for COVID-19

Ionis Pharmaceuticals News About ALS Treatment Attempts

We Continue to Track the COVID-19 Vaccines. See Also: CRISPR Therapeutics Immuno-Oncology Results are Good.

A Great Game Changer for the History of Biotechnology